Exploring the Essential Role of Real-World Data in Drug Development: Join Our Informative Webinar

In an increasingly competitive pharmaceutical landscape, access to high-quality real-world data (RWD) is no longer just a luxury but a necessity. The importance of RWD in developing and commercializing new therapies cannot be overstated. This point is underscored by the upcoming free webinar, 'Harnessing the Power of Real-World Data for New Therapies,' hosted by Xtalks.

Set to take place on November 13, 2025, at 1 p.m. EST, this engaging session is designed to educate attendees about the extensive opportunities that high-quality RWD offers within the pharmaceutical sector. Attendees will get insights into how companies can evaluate various RWD sources—specifically focusing on electronic health record (EHR) data. Moreover, the session will delve into how big data and artificial intelligence are revolutionizing the realm of medical therapies.

One of the significant challenges faced by pharmaceutical companies is the absence of robust RWD, which can hinder effective commercialization strategies. Without reliable RWD, gathering insights pre-launch becomes precarious and complicates tracking of post-launch adoption trends. Especially when specific J-codes are yet to be universally recognized, vital information often lies concealed within clinicians' free-text notes in EHR systems.

The featured speakers for the webinar are industry experts Michael Fronstin, founder of Vireo Strategies LLC; Manfred Stapff, MD, PhD, from Candid - Advisory Inc.; Katherine Vandebelt, CEO of Van de Bytes, and Aracelis Torres, PhD, MPH, Senior Vice President of Data Science at Verana Health. Each brings a wealth of knowledge on how RWD can be harnessed effectively to drive better decision-making and aid in the successful launch of new therapies.

Key topics that will be discussed during this informative session include:
  • - How high-quality RWD, particularly EHR data, can facilitate site selection and enhance patient identification for clinical trials, as well as ease the execution of observational studies that assess safety and efficacy.
  • - The evaluation of EHR RWD sources and the importance of curating unstructured clinical notes.
  • - Showcasing real-world applications of EHR RWD through insightful case studies, including instances addressed in thyroid eye disease therapies.

Participants can expect to leave the webinar equipped with actionable insights into how leveraging RWD can inform sales strategies based on actual market usage and trends. The event promises to illuminate pathways for pharmaceutical professionals striving to ensure their products are based on sound data while meeting both regulatory and market demands.

This event forms part of the RWD in Action Series, and it is encouraged for anyone involved in the pharmaceutical and life sciences industries to attend. To register for the webinar and gain insights into innovative data-driven approaches, visit the Xtalks website.

About Xtalks: Xtalks is a leading provider of educational content and webinars tailored to the life sciences, healthcare, food, and medical device sectors. Consistently drawing thousands of industry participants, Xtalks serves as a platform for professionals eager to stay informed on regulatory updates, industry advancements, and job opportunities. The robust webinar programs also contribute to knowledge sharing among stakeholders, enhancing strategic decision-making in real-world applications. For further inquiries or interest in hosting a webinar with Xtalks, additional information is available through their official channels.

Topics Health)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.